FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144052841> ?p ?o ?g. }

• W2144052841 endingPage "836" @default.
• W2144052841 startingPage "826" @default.
• W2144052841 abstract "The angiotensin-converting enzyme (ACE) inhibitory activity and the concentration of the 2 ACE-inhibiting tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) were studied during cheese ripening in 7 Swiss cheese varieties. The semi-hard cheeses Tilsiter, Appenzeller 1/4 fat, Tête de Moine, and Vacherin fribourgeois and the extra-hard and hard cheeses Berner Hobelkäse, Le Gruyère, and Emmentaler were investigated. Three loaves of each variety manufactured in different cheese factories were purchased at the beginning of commercial ripeness and investigated at constant intervals until the end of the usual sale period. Good agreement was found between ACE-inhibitory activity and the total concentration of VPP and IPP at advanced ripening stages. In most of the investigated varieties ACE-inhibitory activity and the concentration of the 2 tripeptides initially increased during the study period. A decline in the concentration of VPP and IPP was obtained toward the end of the investigated period for Tilsiter and Gruyère. The ratio of VPP/IPP decreased during ripening in all varieties with the exception of Emmentaler. However, large variations were observed among the cheese varieties as well as the individual loaves of the same variety. Chemical characterization of the investigated cheeses revealed that qualitative differences in the proteolysis pattern, not quantitative differences in the degree of proteolysis, are responsible for the observed variations in the concentrations of VPP and IPP. The presence of Lactobacillus helveticus in the starter culture was associated with elevated concentrations of VPP and IPP. The results of the present study show that concentrations of VPP and IPP above 100 mg/kg are attainable in semi-hard cheese varieties after ripening periods of about 4 to 7 mo and that stable concentrations of the 2 antihypertensive tripeptides can be expected over several weeks of cheese ripening." @default.
• W2144052841 created "2016-06-24" @default.
• W2144052841 creator A5023806119 @default.
• W2144052841 creator A5032899021 @default.
• W2144052841 creator A5046997176 @default.
• W2144052841 creator A5048443526 @default.
• W2144052841 creator A5049279886 @default.
• W2144052841 date "2009-03-01" @default.
• W2144052841 modified "2023-09-27" @default.
• W2144052841 title "Hot topic: Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties" @default.
• W2144052841 cites W1501811857 @default.
• W2144052841 cites W1563027263 @default.
• W2144052841 cites W1981915790 @default.
• W2144052841 cites W1987000855 @default.
• W2144052841 cites W1992870108 @default.
• W2144052841 cites W1994118095 @default.
• W2144052841 cites W1994885597 @default.
• W2144052841 cites W1997502528 @default.
• W2144052841 cites W1999722063 @default.
• W2144052841 cites W2001515623 @default.
• W2144052841 cites W2003968309 @default.
• W2144052841 cites W2005353262 @default.
• W2144052841 cites W2011652416 @default.
• W2144052841 cites W2018421600 @default.
• W2144052841 cites W2025771876 @default.
• W2144052841 cites W2030738416 @default.
• W2144052841 cites W2037634860 @default.
• W2144052841 cites W2039281690 @default.
• W2144052841 cites W2044363886 @default.
• W2144052841 cites W2045627198 @default.
• W2144052841 cites W2048958129 @default.
• W2144052841 cites W2049246317 @default.
• W2144052841 cites W2055999435 @default.
• W2144052841 cites W2065156840 @default.
• W2144052841 cites W2075909367 @default.
• W2144052841 cites W2081101065 @default.
• W2144052841 cites W2083671868 @default.
• W2144052841 cites W2092767932 @default.
• W2144052841 cites W2105616599 @default.
• W2144052841 cites W2134511517 @default.
• W2144052841 cites W2139939330 @default.
• W2144052841 cites W2149098516 @default.
• W2144052841 doi "https://doi.org/10.3168/jds.2008-1531" @default.
• W2144052841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19233775" @default.
• W2144052841 hasPublicationYear "2009" @default.
• W2144052841 type Work @default.
• W2144052841 sameAs 2144052841 @default.
• W2144052841 citedByCount "66" @default.
• W2144052841 countsByYear W21440528412012 @default.
• W2144052841 countsByYear W21440528412013 @default.
• W2144052841 countsByYear W21440528412014 @default.
• W2144052841 countsByYear W21440528412015 @default.
• W2144052841 countsByYear W21440528412016 @default.
• W2144052841 countsByYear W21440528412017 @default.
• W2144052841 countsByYear W21440528412018 @default.
• W2144052841 countsByYear W21440528412019 @default.
• W2144052841 countsByYear W21440528412020 @default.
• W2144052841 countsByYear W21440528412021 @default.
• W2144052841 countsByYear W21440528412022 @default.
• W2144052841 countsByYear W21440528412023 @default.
• W2144052841 crossrefType "journal-article" @default.
• W2144052841 hasAuthorship W2144052841A5023806119 @default.
• W2144052841 hasAuthorship W2144052841A5032899021 @default.
• W2144052841 hasAuthorship W2144052841A5046997176 @default.
• W2144052841 hasAuthorship W2144052841A5048443526 @default.
• W2144052841 hasAuthorship W2144052841A5049279886 @default.
• W2144052841 hasBestOaLocation W21440528411 @default.
• W2144052841 hasConcept C134018914 @default.
• W2144052841 hasConcept C167392928 @default.
• W2144052841 hasConcept C172353545 @default.
• W2144052841 hasConcept C181199279 @default.
• W2144052841 hasConcept C185592680 @default.
• W2144052841 hasConcept C27016395 @default.
• W2144052841 hasConcept C2777176278 @default.
• W2144052841 hasConcept C2779281246 @default.
• W2144052841 hasConcept C2779389801 @default.
• W2144052841 hasConcept C2780393073 @default.
• W2144052841 hasConcept C2781307694 @default.
• W2144052841 hasConcept C31903555 @default.
• W2144052841 hasConcept C55493867 @default.
• W2144052841 hasConcept C84393581 @default.
• W2144052841 hasConcept C86803240 @default.
• W2144052841 hasConceptScore W2144052841C134018914 @default.
• W2144052841 hasConceptScore W2144052841C167392928 @default.
• W2144052841 hasConceptScore W2144052841C172353545 @default.
• W2144052841 hasConceptScore W2144052841C181199279 @default.
• W2144052841 hasConceptScore W2144052841C185592680 @default.
• W2144052841 hasConceptScore W2144052841C27016395 @default.
• W2144052841 hasConceptScore W2144052841C2777176278 @default.
• W2144052841 hasConceptScore W2144052841C2779281246 @default.
• W2144052841 hasConceptScore W2144052841C2779389801 @default.
• W2144052841 hasConceptScore W2144052841C2780393073 @default.
• W2144052841 hasConceptScore W2144052841C2781307694 @default.
• W2144052841 hasConceptScore W2144052841C31903555 @default.
• W2144052841 hasConceptScore W2144052841C55493867 @default.
• W2144052841 hasConceptScore W2144052841C84393581 @default.
• W2144052841 hasConceptScore W2144052841C86803240 @default.
• W2144052841 hasIssue "3" @default.

• next